Diagnamed Holdings Corp

NEW
FRA:D75 (Canada)  
€ 0.046 +0.025 (+124.39%) Jul 3
At Loss
Market Cap:
€ 3.66M ($ 4.19M)
Enterprise V:
€ 3.42M ($ 3.92M)
Volume:
2.00K
Avg Vol (2M):
2.00K
Trade In:

Business Description

Description
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
-0.22
Interest Coverage
No Debt
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
-2.2
3-Year EPS without NRI Growth Rate
-11.9
3-Year FCF Growth Rate
26.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
86.84
9-Day RSI
75.63
14-Day RSI
66.52
3-1 Month Momentum %
-46.05
6-1 Month Momentum %
-37.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.82
Quick Ratio
0.82
Cash Ratio
0.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-12.7

Profitability Rank

Name Current Vs Industry Vs History
ROA %
-506.92
ROIC %
-9999999999.99
Moat Score
2
Tariff Resilience Score
6

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-4.08
EV-to-EBITDA
-4.08
EV-to-FCF
-9.15
Earnings Yield (Greenblatt) %
-24.51
FCF Yield %
-10.22

Financials

FRA:D75's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Diagnamed Holdings Corp Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.016
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 66.52
14-Day ATR (€) 0.005944
20-Day SMA (€) 0.0223
12-1 Month Momentum % -
52-Week Range (€) 0.013 - 0.152
Shares Outstanding (Mil) 131.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diagnamed Holdings Corp Filings

Filing Date Document Date Form
No Filing Data

Diagnamed Holdings Corp Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Diagnamed Holdings Corp Frequently Asked Questions

What is Diagnamed Holdings Corp(FRA:D75)'s stock price today?
The current price of FRA:D75 is €0.05. The 52 week high of FRA:D75 is €0.15 and 52 week low is €0.01.
When is next earnings date of Diagnamed Holdings Corp(FRA:D75)?
The next earnings date of Diagnamed Holdings Corp(FRA:D75) is .
Does Diagnamed Holdings Corp(FRA:D75) pay dividends? If so, how much?
Diagnamed Holdings Corp(FRA:D75) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Diagnamed Holdings Corp

No articles.